fda

Eli Lilly Pauses Covid-19 Antibody Trial Over Safety Concerns

Eli Lilly Pauses Covid-19 Antibody Trial Over Safety Concerns

Pharmaceutical company Eli Lilly is the latest to temporarily halt one of its covid-19 clinical trials. The Phase III trial, involving an experimental antibody treatment for patients with the viral illness and sponsored by the federal government, was paused due to a “potential safety concern,” according to government emails obtained…